Patent Assignment
Reel/Frame 063729/0726
Assignment of Assignor's Interest
Recorded: 2023-05-23
Pages: 7
Assignee
REATA PHARMACEUTICALS, INC.
2801 GATEWAY DRIVE, SUITE 150, IRVING, TEXAS, 75063
Covered Property
(1)
Co-Crystal Forms of a Novobiocin Analog and Proline
Application:
18/168,495 →
Publication:
US 2024/0043465
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Patent Security Agreement
May 18, 2023
From: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063697/0461 →
Assignment of Assignor's Interest
May 23, 2023
From: BEVILL, MELANIE J; SEADEEK, CHRISTOPHER S; SMIT, JARED P
To: ALBANY MOLECULAR RESEARCH, INCORPORATED
Reel/Frame 063729/0976 →
Assignment of Assignor's Interest
May 23, 2023
From: ALBANY MOLECULAR RESEARCH, INCORPORATED
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 063730/0093 →
Amended and Restated Patent Security Agreement
Jul 12, 2023
From: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064264/0557 →
Release of Security Interest
Apr 9, 2025
From: BIOPHARMA CREDIT PLC
To: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
Reel/Frame 070793/0130 →
Release of Security Interest
Apr 9, 2025
From: BIOPHARMA CREDIT PLC
To: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
Reel/Frame 070793/0228 →